ArticleEuropean archives of psychiatry and clinical neuroscience2026
Psychometric properties of the PANSS autism severity score (PAUSS) in young peoples at clinical high risk for psychosis: does it really measure autistic features?
Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The PANSS Autism Severity Score (PAUSS) is a commonly used measure for autistic features in early psychosis, including in adolescents at Clinical High Risk (CHR). However, no research examining its psychometric properties in this at-risk population has been published to date. Therefore, we explored reliability, validity, and longitudinal course of PAUSS scores in a sample of young CHR individuals treated in an early intervention service in Italy during 2 years of follow-up. Participants completed the Autism-spectrum Quotient (AQ) and the Positive And Negative Syndrome Scale (PANSS) at baseline and annually during the follow-up. Cronbach's α statistics were used for internal consistency, while Cohen's k statistics and Spearman's correlation coefficients (ρ) were used for convergent validity with AQ scores and longitudinal stability. In the 214 recruited CHR participants, Cronbach's value was 0.849, but the PANSS G5 item showed unacceptable inter-item and item-total correlations. Furthermore, Cohen's k value in relation to AQ scores was unacceptable (0.022), as were ρ (< 0.750) and k (< 0.600) values for longitudinal stability. The results of this research suggest that the PAUSS may not be a valid tool for assessing autistic characteristics in CHR individuals. In fact, it may detect attenuated psychotic symptoms and their transient psychopathological severity, rather than being a reliable indicator of autistic features. Alternatively, its poor discriminatory ability could also reflect contamination of autism measurement by concurrent psychopathology. Therefore, it should never replace careful clinical judgment and the use of appropriate instruments for the diagnosis of ASD.
Indexed as
Identifiers
42762240What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.